Skip to main content
TECX logo

TECX · Tectonic Therapeutic, Inc. · Holdings

Track TECX — free
$21.04 +0.00 (+0.00%) At close · Nov 19
Market Cap
$419.71M
Shares
19.95M
Volume · Nov 19 87.18K Avg daily vol (3M) 210.71K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 116
Total Value: $332,826,557
Total Shares: 14,290,538
Showing 1–100 of 123 holdings by value · page 1 of 2

Institutional Ownership Trend

27 quarters

Holder Concentration

Share of 13F common-share value, across 116 filers with any position, options included · Δ vs Jun 30, 2026
Top Holder
20.5%
Dec 2023 → Sep 2026 · range 17.0% – 29.4%
+0.3 pts
Top 5
43.5%
Dec 2023 → Sep 2026 · range 43.5% – 65.3%
−5.5 pts
Top 10
59.6%
Dec 2023 → Sep 2026 · range 59.6% – 86.3%
−8.9 pts
HHI
664
Dec 2023 → Sep 2026 · range 664 – 1,359
Broadly held−70

Who Holds TECX

Last 8 quarters through Sep 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Sep 30, 2026: 116 filers, like-for-like change +2.3%; actively managed books +7.7%; index-like books -14.6%.

Holder type Share Filers Change
Registered adviser 41.1% 53 -2.2%
Exempt adviser 6.0% 4 +370.0%
Adviser 1.4% 3 -3.1%
Bank 4.1% 13 +0.9%
Broker-dealer 0.9% 1 +202.6%
Benefit plan 0.1% 2 +99.0%
Non-US 0.1% 4 -44.6%
Holding company 32.1% 8 -8.6%
Unknown 14.3% 28 +6.9%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Conviction and Crowding

116 13F filers, quarter ended Sep 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
1
0.862% of filers hold it in their top 10
Jun 30, 2026: 1
Holders above 5%
0
median weight 0.001%
Jun 30, 2026: 1
Crowding
31.9%
of shares outstanding, 83rd percentile
Jun 30, 2026: 30.5%
Private-fund advisers
29.2%
of shares outstanding
Institutional ownership
73.1%
117.1% of the estimated free float above 100%: filers can report lent or client shares more than once
Top 10 holders
59.6%
of 13F shares, Herfindahl 0.066
Active holders
+7.7%
like-for-like share change of active filers
5% stakes on record
5
3 13D, 2 13G (1 institutional, 1 passive, 0 exempt)
How long holders have held it value-weighted 6.3 quarters
Under 1 year 30.2% 1 to 3 years 69.8% 3 years or more 0.000% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net sellers of $4,669,233 (5 buying, 8 selling).

Estimated Holder Cost Basis

Quarter ended Sep 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$25.16
estimated per share
Jun 30, 2026: $23.28
Quarter-end price
$23.29
implied by 13F values
Estimated gain or loss
-7.4%
price against the estimated cost
Estimated at a loss
65.0%
of costed 13F value

Estimated cost covers 56.4% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies TECX's active holders also own, quarter ended Sep 30, 2026
# Company Shared holders
1 IMTX Immatics N.V. 7
2 AVTX Avalo Therapeutics, Inc. 8
3 SKYE Skye Bioscience, Inc. 3
4 PRLD Prelude Therapeutics Inc 3
5 CLDX Celldex Therapeutics, Inc. 7
6 ALXO Alx Oncology Holdings Inc 4
7 IMUX Immunic, Inc. 4
8 ELVN Enliven Therapeutics, Inc. 7
9 DRUG Bright Minds Biosciences Inc. 5
10 PMN ProMIS Neurosciences Inc. 3

Shareholder Targets

13F filers that own its peers but not TECX, quarter ended Sep 30, 2026

Found through its holder-overlap peers: IMTX, AVTX, SKYE, PRLD, CLDX, ALXO, IMUX, ELVN, DRUG, PMN, PALI, GLUE, SLN, PHVS, TRDA, TRAX, CBIO, TYRA, QTTB, AVBP. 458 filers in all.

# Filer In peers
1 Polar Capital Holdings Plc Registered adviser, Diversified active $383,140,054 2 held
2 RA CAPITAL MANAGEMENT, L.P. Registered adviser, Concentrated $367,630,371 7 held
3 JANUS HENDERSON GROUP PLC Adviser, Diversified active $288,023,725 10 held
4 SUVRETTA CAPITAL MANAGEMENT, LLC Registered adviser, Diversified active $272,791,976 5 held
5 Commodore Capital LP Registered adviser, Concentrated $265,213,580 5 held
6 ADAGE CAPITAL PARTNERS GP, L.L.C. Registered adviser, Diversified active $247,745,470 12 held
7 BVF INC/IL Unknown, Concentrated $228,818,755 6 held
8 T. Rowe Price Investment Management, Inc. Adviser, Diversified active $220,809,580 1 held
9 Affinity Asset Advisors, LLC Registered adviser, Diversified active $204,786,726 9 held
10 Point72 Asset Management, L.P. Registered adviser, Systematic-like $204,497,966 14 held

Fund Ownership of TECX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 7.08% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 1.79% 356,485
Index ETFs 5.30% 1,056,430
Active ETFs 0.04% 8,578
Active funds 14.99% 2,989,508
Unclassified 0.69% 138,197
All registered funds 22.81% 4,549,198
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Jun 30, 2026
New
12
Increased
48
Decreased
29
Sold Out
19
Unchanged
27

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: -7
Institutional value: -30.7%
Shares held: +2.3%

Top Buyers

vs Jun 30, 2026
Institution Added Now Holds Open

Top Sellers

vs Jun 30, 2026
Institution Sold Now Holds Open

Top New Positions

vs Jun 30, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jun 30, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 123
Export CSV
Holder Value (USD) % of 13F Shares Own % Change Type Filed Open

Showing the top 100 of 123 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1681087 CUSIP 878972108 13F (30d) 116 filings 110 filers Visit website Investor relations